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Influenza A viruses are characterized by high genetic diversity due to error-prone replication, 
large population sizes, and strong natural selection. While most of what we know about influenza 
evolution has come from population scale epidemiological studies based on the analysis of a 
limited number of consensus sequences, these are limiting for outbreak investigations. The 
analysis of virus genetic diversity present in an infected host provides a richer genetic fingerprint 
with which to infer host-to-host virus transmission. Despite the use of animal models to 
characterize extent of intra-host diversity and what proportion of this diversity that is transmitted 
between individuals, less is known about these key evolutionary parameters in human 
populations. To quantify and characterize influenza virus variants that can achieve sustainable 
transmission in new hosts, we used household donor/recipient pairs of infected individuals from 
a Hong Kong community during the first wave of the 2009 H1N1 pandemic when seasonal 
H3N2 was also co-circulating. While the same variants were often found in multiple members of 
the community during the epidemic, the relative frequencies of variants fluctuate, with patterns 
of genetic variation more similar within than between households. We estimated the effective 
population size of influenza A virus across these donor/recipient pairs to be in the range of 100-
200 contributing members, which enabled the transmission of multiple virus lineages among 
individuals, including antigenic variants. 
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1.0  INTRODUCTION 
Influenza A virus is a single stranded RNA virus that infects millions of people every year 
worldwide. Its error-prone RNA-dependent RNA polymerase leads to high genetic diversity. 
Even with the availability of vast clinical data, questions remain on what is the intra-host virus 
genetic diversity, what constitutes an effective dose and what is the genetic bottleneck at 
transmission.  
The advent of high throughput sequencing, such as Next Generation Sequencing (NGS), 
has enabled the rapid genomic characterization of clinical samples from influenza-infected 
individuals. We developed a pipeline to analyze high throughput data from Illumina HiSeq, 
taking into consideration the high read coverage (up to 6000x), PCR errors, and sequence 
specific errors to identify real mutations due to the error prone polymerase of the RNA virus. 
Using this approach, we characterized the intra-host genetic diversity of influenza virus 
populations collected from nasal swabs of individuals infected during the 2009 H1N1 pandemic 
in Hong Kong where seasonal H3N2 was also co-circulating. Samples were collected from index 
cases and their household contacts; some individuals were sampled at two different time points. 
By sequencing the viruses present in these samples, we reconstructed the virus population 
structure over time and after transmission events. By looking at virus genetic data beyond the 
consensus, we were able to identify multiple strains within individuals and circulating during the 
epidemic, and observed that certain strain frequencies fluctuated over time.  
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Our goal was to determine how intra-host viral evolution influences inter-host viral 
transmission in a natural environment. We compared variants that are shared between hosts with 
those that arise by de novo mutation. We then identified relationships between samples, observed 
potential transmission links, and estimated the effective number of virions transmitted that are 
contributing members to the infection in contact cases. 
1.1 WHY STUDY INFLUENZA? 
Influenza A viruses are a consistent threat and a burden to human health. These pathogens cause 
respiratory tract infections, and in severe cases cause high morbidity and mortality. Most people 
with influenza-like illness, including cough and fever within 48 hours of symptom onset, are 
likely to have influenza (1). In the United States alone, 36,000 people die annually of influenza 
A virus infections (2). The 2009 H1N1 pandemic is thought to have infected 0.01% of the world 
population and resulted in 284,000 deaths worldwide (3). The phylogeny of influenza A is 
marked by antigenic cluster jumps, which have occurred on average every 3 years, and typically 
correspond to occurrences of vaccine failure (2).  
Influenza viruses are of the family Orthomyxoviridae and are single-stranded, negative 
sense RNA viruses. Type A has greater genetic diversity than types B and C viruses, and infects 
the widest range of host species, including birds, swine, horses, and humans (2). The total length 
of the viral genome is around 13 Kb and has eight distinct segments encoding 10-11 proteins (4). 
The segmented genome can undergo reassortment, which occurs when two or more viruses infect 
the same cell and the resulting new viral particles contain RNA segments from each of the 
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“parental” viruses. This can provide an evolutionary advantage because segments of the virus 
can reassort to create antigenically novel strains, potentially leading to pandemics (4). 
The two surface proteins, hemagglutinin (HA) and neuraminidase (NA), exhibit greater 
amino acid variability than other proteins. The HA binds to cell surface receptors and allow the 
virus to penetrate into the cytoplasm while the NA enables budding of new virions from the 
infected cell. There are 16 HA and 9 NA subtypes. Within a single subtype (such as H3N2) there 
can be multiple and diverse viral lineages co-circulating—including antigenic variants. Co-
infection of cells can lead to reassortment and contribute to intra-host diversity (5). 
1.2 INTRA-HOST DIVERSITY 
We refer to intra-host diversity as the genetic variation of the virus population within the infected 
host. Intra-host diversity is due to the error-prone RNA-dependent RNA polymerase of the virus 
and to the host’s immune status. This diversity allows the viruses to transition into new genetic 
space after being exposed to selective pressures, such as host immunity or antiviral treatment (6). 
In molecular epidemiology studies of influenza, intra-host diversity is overlooked and most of 
the focus is on the consensus sequence (i.e. the genetic average of individual variants in a 
population). What we then observe is a stark contrast between the vibrant mutant spectrum of 
influenza diversity and a single static consensus sequence of influenza. This becomes important 
because even in rapidly mutating populations, the emerging variant is detectable before the 
mutation becomes fixed (7). Longitudinal studies of influenza show that the mutational spectrum 
of influenza can change considerably over time (8). The new variants and phenotypes may 
persist without changing the consensus sequence and in some cases fixation may never occur (7). 
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However, the immune status of the host (naïve, previously exposed or vaccinated) can lead to 
different patterns of sequence diversity, and variants of the former may have antigenic 
significance. Identifying variants that become fixed are potential clues as to the presence of 
variants of interest that may exist as minor populations. 
1.3 THE TRANSMISSION BOTTLENECK 
The transmission of influenza can occur by direct contact, aerosol or droplet transmission. A 
recent study of infected individuals demonstrates that in infected patients, as many as 105 viral 
copies can be excreted over a 30 minute period by aerosol (9). In addition, aerosol administration 
to volunteers found that the minimal infectious dose can be fewer than 10 virions (10). 
Asymptomatic infected hosts can also be infectious (11). Infectious influenza virions can 
originate from the upper respiratory tract and may be the source for direct and airborne 
transmission events (12). There are several processes that can affect the bottleneck during 
transmission. A low infectious dose could severely limit the number of particles transmitted and 
cause a founder effect, which would reveal very low genetic diversity immediately after 
transmission (13). Another factor could be selective pressures of the host, where diversity is 
diminished as natural selection would eliminate viruses not fit enough for establishment of 
infection (13).   
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2.0  QUANTIFYING INFLUENZA VIRUS DIVERSITY AND TRANSMISSION IN 
HUMANS 
2.1 INTRODUCTION 
Influenza A viruses are characterized by high genetic diversity due to error-prone replication, 
large population sizes, and strong natural selection (14-16). While most of what we have learned 
about influenza evolution has come from population level epidemiological studies based on the 
analysis of consensus sequences (17) they are limiting for outbreak investigations. The analysis 
of virus genetic diversity present in an infected host provides a richer genetic fingerprint with 
which to infer virus transmission from host to host (18-22). Despite attempts to characterize 
intra-host diversity and the transmission bottleneck of the influenza A virus in various animal 
models (19, 23) it is still not well understood for human populations (24). To characterize 
patterns of viral evolution at a finer-scale, we performed deep sequencing on nasopharyngeal 
swabs collected from index cases with confirmed influenza along with their household contacts. 
We have previously shown that pandemic H1N1 and seasonal H3N2 viruses—both 
present during the first wave of the H1N1 pandemic in Hong Kong (25)—have similar 
transmission potential in household settings, and that different antigenic variants of H3N2 co-
circulated with different clades of H1N1/2009 (25, 26). In other parts of the world, and during 
the same time period, the unseasonal transmission of H3N2 was observed along with pandemic 
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H1N1 virus (27). To quantify and characterize influenza virus variants that can achieve 
sustainable transmission, we used household donor/recipient pairs of infected individuals from 
this Hong Kong community. To characterize patterns of viral evolution at a finer-scale, we 
performed deep sequencing on nasopharyngeal swabs collected from index cases with confirmed 
influenza along with their household contacts. We captured whole genome data and genetic 
diversity of the virus population within each infected patient. The household epidemiological 
information enables us to assign with relatively high confidence donor/recipient pairs in 
suspected transmission events and compare with unrelated pairs, all while estimating spatio-
temporal transmission chains. We estimated the effective population size that enabled the 
transmission of multiple virus lineages among individuals, including antigenic variants.  
2.2 MATERIALS AND METHODS 
2.2.1 Sample collection  
Retrospective pooled specimens of nasal and throat swabs studied in a previous household 
influenza transmission investigations (28, 29) were subjected to next generation sequencing. This 
dataset comprises 102 virus samples (55 H1N1/2009 and 47 H3N2) collected from 86 
individuals in Hong Kong over July and August 2009. There were multiple home visits and 16 
individuals were sampled twice on 2 or 3 household visits (visit 1, V1; visit 2, V2; visit 3, V3), 
2-4 days apart. 
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2.2.2 Sample preparation, sequencing and variant calls.  
Multi-segment reverse-transcription PCR (M-RT-PCR) (28) was used to amplify influenza-
specific segments from total RNA, followed by sequence independent single primer 
amplification (SISPA) (29). Each RNA sample was subjected to 2 rounds of M-RT-PCR and 
these in turn were amplified by SISPA using different barcodes to control for barcode-specific 
amplification bias; these technical replicates were then pooled separately for 100 bp paired-ends 
sequencing on different lanes of a HiSeq2000 sequencer (Illumina). Potential SISPA PCR 
duplicate reads were removed with the JCVI ELVIRA package 
[http://sourceforge.net/projects/elvira/]. SISPA barcoded reads were demultiplexed with JCVI 
DNA Barcode Deconvolution software [http://sourceforge.net/projects/deconvolver/]. CLC Bio 
software was used to map barcode-trimmed reads to a reference genome and to remove low 
quality reads. Minor variants were identified using the JCVI ELVIRA package. 
2.2.3 Variant analysis 
Minor variants were identified using the JCVI ELVIRA package, which applies statistical tests to 
minimize false positive single nucleotide variants (SNV) calls that can be caused by sequence 
specific errors (SSE) that may occur in Illumina platforms (30). This involves observing the 
forward and reverse reads of a SNV call; based on a binomial distribution cumulative 
probability, we calculate the p-values. If both p-values are within a Bonferroni-corrected 
significance level (alpha = .05), the SNV call is accepted. A minimum minor allele frequency of 
3% was used as the threshold; this cutoff was based on the same control sample that was 
sequenced in two different sequence runs, and then examining concordance (SNV found in both 
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samples) and discordance (SNV found in only one of 2 samples) for different frequency 
thresholds. At 3%, 16/17 sites were concordant, while at 4% 14/14 sites were concordant. We 
chose the lower cut-off to gain more information, even if the error was higher. 
2.2.4 Quantification of intra-host diversity 
We used Shannon entropy to quantify the intra-host diversity of each sample through the relative 
frequencies of each single nucleotide variant using the short read (Illumina) data. This was done 
across all segments and assumes that all SNVs are independent of each other. We find that the 
entropy scores between H1N1/2009 and H3N2 are significantly different from each other (p = 
1.27E-06).    
𝐻(𝑥) = ∑ 𝑃(𝑖) log2 𝑃(𝑖)
𝑛
𝑖
 
Equation 1 - Shannon entropy 
Where 𝑃(𝑖) is the relative frequency of a variant at position i. 
 
2.2.5 Genetic distance across samples  
We compare each sample against every other sample (all-versus-all pairwise comparison) at each 
variant nucleotide position using an L1-norm:  
𝑑𝑘(𝑝, 𝑞) = ∑ |𝑝𝑖 − 𝑞𝑖|
𝑛
𝑖=1
 
Equation 2 - L1-norm distance 
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Here dk is the distance measured at nucleotide position k between two samples. n is the 
total number of possible nucleotide configurations (A, C, G, T). p and q are vectors containing 
the relative frequencies of the different variant nucleotides observed (these are analogous to 
“alleles”).  
Between two samples we observe a nucleotide position of a coding sequence (dk) and 
then sum over all positions to obtain D, the distance measured between two samples for a 
specific coding sequence (CDS); N is the length of the CDS.  
𝐷 = ∑ 𝑑𝑘
𝑁
𝑘=1
 
Equation 3 - Dissimilarity distance 
This results in a single number that informs us of the distance (or dissimilarity) between 
two samples for each of the coding sequences. This was repeated across all segments.  
We verified our analysis by comparing against two other distance measures. The L2-
norm uses Euclidean distance and follows a similar procedure to the L1-norm with dk computed 
as such:  
 
𝑑𝑘(𝑝, 𝑞) = √∑(𝑝𝑖 − 𝑞𝑖)2
𝑛
𝑖=1
 
Equation 4 - L2-norm measure 
D is similarly calculated by summing over all values of dk. 
The third method we used was the Jensen-Shannon divergence (JSD). The JSD modifies 
the Kullback-Leibler divergence so that the resulting output is symmetric and will always have a 
finite value: 
 10 
𝐷𝐾𝐿(𝑃||𝑄) =  ∑ ln (
𝑃(𝑖)
𝑄(𝑖)
)
𝑖
𝑃(𝑖) 
Equation 5 – Kullback-Leibler divergence 
The JSD is calculated by: 
𝐷𝐽𝑆𝐷(𝑃||𝑄) =  
1
2
𝐷(𝑃||𝑀) +
1
2
𝐷(𝑄||𝑀) 
Equation 6 - Jensen-Shannon divergence 
where  
𝑀 =   
1
2
(𝑃 + 𝑄) 
Equation 7 - JSD probability measure (M) 
A t-test was used to score significance between the three methods (data not shown). Since 
no significance was found, we used the L1-norm. 
 
2.2.6 Estimating the virus effective population size 
We used a modified version of the Wright-Fisher idealized population model (31) to estimate the 
effective population size of influenza A virus from the shared SNVs in our donor/recipient pairs. 
This model assumes the population does not grow or shrink, there are discrete generations, that 
every generation is “replaced” by offspring, and that each of the variant sites is independent. We 
then calculate a variance effective size, the size of a Wright-Fisher population with the same 
variance,  
𝑁𝑖 =  
𝐸[𝑝𝑗]𝐸[𝑞𝑗]
2𝑣𝑎𝑟(∆)
 
Equation 8 -- Modified Wright-Fisher idealized population model 
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where 𝑁 is the effective population size for a given nucleotide position i, q is the major 
variant frequency of a donor j, and 𝑝 is the minor variant frequency of j. For variants that were 
shared by all donors for a given strain with a frequency greater than 0.01 (1%), we calculated the 
change in variant frequency between donor and recipients for all pairs,   
∆ = 𝑝𝑗 − 𝑝𝑗
′  
Equation 9 - Delta of donor and recipient frequencies 
with 𝑝𝑗
′  being the minor variant frequency of the recipient. The variance in this quantity 
appears in the effective size formula. For H1N1, the size of j is 8 unique donor-recipient pairs 
with 21 shared variants. The equivalent values for H3N2 are j of 6 unique donor/recipient pairs 
with 81 shared variants.  
To confirm the scale of our estimates, we employed a second method that utilizes 
Kullback-Leibler divergence to measure Ebola virus transmission (32). The aim of this approach 
is to measure the distance from a true probability distribution, q, to a target probability 
distribution, p, which are our donor and recipient populations, respectively, and use their 
similarity to estimate the number of times the donor distribution was sampled. As with the 
Wright-Fisher approach, this assumes independence between variant sites and will consequently 
return a lower bound estimate (?̂?) on infectious dose size.  
 
?̂?  =  
s
2 ∑ 𝐾𝐿(𝑞𝑖|𝑝𝑖)
𝑆
𝑖
< 𝑁𝑒𝑓𝑓 
Equation 10 - Modified Kullback-Leibler divergence estimate 
The number of shared variants between donor and recipient is represented by s. A variant 
has to be shared by both donor and recipient to be included. 𝐾𝐿(𝑞𝑖|𝑝𝑖) is the Kullback-Leibler 
divergence from 𝑞𝑖 to 𝑝𝑖, where 𝑞𝑖 is the set of nucleotide frequencies found in the donor at 
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position i and 𝑝𝑖 is the set of nucleotide frequencies found in the recipient at the same site. This 
value is summed over the variant positions across all segments where a shared variant is 
discovered on both the donor and recipient. We calculated this for each donor/recipient pair for 
H1N1/2009 and H3N2.  
 
2.2.7 Phylogenetic analyses 
All eight influenza A coding sequences were concatenated into an alignment of 13,392 
nucleotides (nt) for H1N1/2009, and 13,425 nt for H3N2. Coding sequences were concatenated 
in the order of the segment number on which they were encoded (PB2-PB1-PA-HA-NP-NA-M1-
M2-NS1-NS2). All isolates were included except for 781_V1(0), which appeared to be a 
reassorted isolate, encoding genes related to both H1N1 and H3N2 strains. Other taxa not 
included in this study were used as outgroup taxa (A/California/04/2009 and A/New 
York/55/2004 for H1N1/2009 and H3N2, respectively). These were selected based on their 
position in widely sampled single gene phylogenies (data not shown). Two additional taxa—
A/Brisbane/10/2007 and A/Nanjing/1/200—were included in the H3N2 phylogeny to capture the 
full diversity of this part of the H3N2 tree. Maximum likelihood phylogenies were generated 
with raxML (33) using the GTR nucleotide substitution model, with among-site rate variation 
modeled using a discrete gamma distribution using four rate categories. Bootstrap support values 
were generated using 1,000 fast bootstrap replicates, and represented as percentages on nodes 
(values below 50% not shown). 
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2.2.8 Haplotype reconstruction by single molecule sequencing  
SNVs identified by Illumina sequencing were phased into haplotypes by SMRT sequencing on 
the PacBio platform for 6 of our donor/recipient pairs using the viral isolates (H1N1/2009 
681_V1(0)/681_V3(2), 742_V1(0)/742_V3(3), 779_V1(0)/779_V2(1); H3N2: 
720_V1(0)/720_V2(1), 734_V1(0)/734_V3(2), 763_V1(0)/763_V2(3)). DNA library preparation 
and sequencing were performed according to the manufacturer’s instructions and reflect the P6-
C4 sequencing enzyme and chemistry, using 4-hour movie collection parameters. Each barcoded 
influenza M-RTPCR cDNA was assessed by Qubit analysis and DNA 12000 Agilent 
Bioanalyzer gel chip to quantify the mass and size distribution of the double-stranded cDNA 
present.  After quantification, samples were pooled in batches of 2-3 samples per SMRTbell 
library preparation as follows. The barcoded amplicon pools were then re-purified using a 1.8X 
AMPure XP purification step (1.8X AMPure beads added, by volume, to each sample in 200 µL 
EB, vortexed for 10 minutes at 2,000 rpm, followed by two washes with 70% alcohol and finally 
diluted in EB). This AMPure XP purification step assures removal of any damaged fragments 
and/or biological contaminant. After purification, ~100 ng of each of the purified, unsheared 
samples was taken into end-repair, which was incubated at 25ºC for 5 minutes, followed by the 
second 1.8X Ampure XP purification step. Next, 0.75 µM of Blunt Adapter was added to the 
cDNA, followed by 1X template Prep Buffer, 0.05 mM ATP low and 0.75 U/µL T4 ligase to 
ligate (final volume of 47.5 µL) the SMRTbell adapters to the DNA amplicons. This solution 
was incubated at 25ºC overnight, followed by a 65ºC 10-minute ligase denaturation step. After 
ligation, the library was treated with an exonuclease cocktail to remove un-ligated DNA 
fragments using a solution of 1.81 U/µL Exo III 18 and 0.18 U/µL Exo VII, then incubated at 
37ºC for 1 hour. Two additional 1.8X Ampure XP purifications steps were performed to remove 
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any adapter dimer or molecular contamination. Upon completion of library construction, samples 
were validated using another Agilent Bioanalyzer DNA 12000 gel chip as well as Qubit analysis.  
For all cases, the yield was sufficient and primer was annealed to the SMRTbell libraries for 
sequencing. The polymerase-template complex was then bound to the P6 enzyme using a ratio of 
10:1 polymerase to SMRTbell at 0.5 nM for 4 hours at 30ºC and then held at 4ºC until ready for 
magbead loading, prior to sequencing.  The magnetic bead-loading step was conducted at 4ºC for 
60-minutes per manufacturer’s guidelines. The magbead-loaded, polymerase-bound, SMRTbell 
libraries were placed onto the RSII machine at a sequencing concentration of 50 pM and 
configured for a 240-minute continuous sequencing run to allow for the maximum number of 
passes for consensus error-correction through the reads of insert protocol version 2.3.0. 
Sequencing was conducted to ample coverage using a single SMRTcell for each of the sample 
pools, where reads were rigorously filtered using a 10-pass, 95% single molecule CCS filter 
criteria to yield ~23,000 – 25,000 post-filtered reads per SMRTcell for each of the pooled sample 
sets. Continuous long read data with 21-26 single-molecule passes, and ~99.2% accuracy was 
generated and produced filtered CCS FASTA and FASTQ files were generated for variant 
calling, after completing the RS_ReadsOfInsert.1 pipeline version 2.3.0. 
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2.3 RESULTS 
2.3.1 Intra-host diversity of Hong Kong samples 
The virus sample set was collected in July and August 2009 from 86 individuals (67 index 
patients and 17 other household members) living in Hong Kong; 16 patients were sampled twice, 
2-4 days apart. We estimated intra-host virus diversity for each sample by mapping polymorphic 
sites onto the consensus genome assemblies to generate a list of single SNVs (or minor variants) 
present at a frequency of at least 3%. Intra-host diversity was calculated as the Shannon entropy, 
H, by summing the entropies for each such site, assuming site independence. Mean intra-host 
diversity was significantly higher (Wilcoxon rank-sum test p = 1.89e-12) for H3N2 (H = 33) 
than H1N1/2009 (H = 13). There was no significant Pearson correlation between high intra-host 
virus diversity and high viral titer [13] (r = -0.3 for H1N1 and r = -0.16 for H3N2) for most of 
the genes, with the exception of PA and M for H1N1/2009 (Table 1). 
Table 1 - Pearson's correlation between quantitative viral loads (qPCR) and variant counts 
strain passage segment p value 
# of 
samples 
H1N1/2009 P0 PB2 0.68 53 
H1N1/2009 P0 PB1 0.16 53 
H1N1/2009 P0 PA 0.02 53 
H1N1/2009 P0 HA 0.15 53 
H1N1/2009 P0 NP 0.16 53 
H1N1/2009 P0 NA 0.80 53 
H1N1/2009 P0 MP 0.02 53 
H1N1/2009 P0 NS 0.81 53 
          
H3N2 P0 PB2 0.25 45 
H3N2 P0 PB1 0.60 45 
H3N2 P0 PA 0.23 45 
H3N2 P0 HA 0.65 45 
H3N2 P0 NP 0.43 45 
 16 
H3N2 P0 NA 0.39 45 
H3N2 P0 MP 0.73 45 
H3N2 P0 NS 0.64 45 
Data indicate that there is correlation between genetic diversity and viral load only for the M and 
PA segments in the nasopharyngeal swabs. P0 = nasopharyngeal swabs, no passage. Significance 
is p < 0.05.  
qPCR data available at http://web.hku.hk/~bcowling/influenza/HK_H1N1_study.htm 
2.3.1.1 Phylogenetic analysis 
Phylogenetic analysis clustered whole genome consensus sequences by household for each group 
of patients diagnosed as being infected with either H1N1/2009 (Figure 1) or H3N2 (Figure 2). 
Phylogenetic analyses of each gene individually provided no evidence for reassortment within 
this population during the timeframe of the study (data not shown).  
Three clades of H1N1/2009 (clades 3, 6 and 7) and three antigenic sublineages of H3N2 
(A/Brisbane/10/2007-like, A/Victoria/2008/2009-like, and A/Perth/16/2009-like) circulated in 
this population (34). Despite the relatively small population size, one case of mixed subtype 
infection was observed, indicating that dual infection with seasonal and pandemic strains may 
not be a rare event (35).  
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Figure 1 - Maximum likelihood phylogenies of concatenated genomes for H1N1/2009. 
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Figure 2 - Maximum likelihood phylogenies of concatenated genomes for H3N2 
M1/M2 and NS1/NS2 genes were represented as one segment for each covering the sequence 
between the first ATG to the last stop codon. Bootstrap support values are shown as percentages 
on nodes. Values below 50% were treated as equivocal and not shown on the figure. Public 
sequences downloaded from GenBank for use as out groups, or included within the diversity of 
the samples, are colored in blue. One patient, 781_V1(0), was shown to also be infected with 
H1N1/2009 clade 7 after having been diagnosed with H3N2 strain A/Victoria/2008/2009-like. 
Only the HA and NA from the H1N1/2009 could be unambiguously assembled from this 
individual (accession CY115455 and CY115458), while a whole genome was assembled for the 
H3N2. Note that scales are different for both trees. Households with more than one member are 
colored. 
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2.3.2 Shared SNVs and haplotype phasing 
We compared SNVs across samples to determine if minor variants were shared within and 
between households.  
 
Figure 3 - Comparison of HA minor variant frequencies across households in H1N1/2009 
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Figure 4 - Comparison of HA minor variant frequencies across households in H3N2 
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Only polymorphic sites located in the HA1 domain are represented. The amino acid positions 
were numbered according to the first methionine (start codon) of the protein (and not according 
to the HA1 numbering schema). The x-axis lists samples by position on the phylogenetic trees in 
Fig. 1 or Fig. 2; households with more than one member are colored. The y-axis displays 
nucleotide frequencies with graph lines corresponding to 0, 25%, 75% and 100% frequency. 
ORF = open reading frame; Antigenic site = previously identified as corresponding to antigenic 
sites. Text in red highlights non-silent mutations located in antigenic sites. Closed circles 
represent minor variants found at a frequency 3% and higher, while open circles correspond to 
frequencies equal or higher than 1%, but below 3%. Boxes show how minor variant nucleotides 
are phased on the same molecules, representing haplotypes. These were determined from single 
molecule sequencing of cell culture viruses for 6 household pairs: H1N1/2009 
681_V1(0)/681_V3(2), 742_V1(0)/742_V3(3), 779_V1(0)/779_V2(1); H3N2: 
720_V1(0)/720_V2(1), 734_V1(0)/734_V3(2), 763_V1(0)/763_V2(3). 
 
 
For both H1N1/2009 (Figure 3) and H3N2 (Figure 4) we observed multiple positions in HA—
including potential antigenic sites—where the minor variant nucleotide in one clade or strain 
became the major nucleotide in another, with evidence of mixed infection at many other sites 
across the genome (see Appendix). To confirm these findings observed from the clinical 
specimens, we phased the SNVs into haplotypes by single molecule sequencing for 12 of the cell 
culture samples from 6 different households. 
Notably, although the consensus sequence points towards the sample belonging to one 
strain, the patient is often infected with two or more strains; many of these variants could be 
detected in multiple families. This, along with the haplotype information, suggests that a number 
of the SNVs are not de novo mutations that occurred in the household's index patient, but are 
shared across the community as a whole. We see a similar phenomenon when looking at global 
consensus sequences across seasons. Using human 2008 H3 sequences as a reference, we 
observed a shift of nucleotide frequency at some positions in subsequent seasons of H3N2 
epidemics (Figure 5). 
 
 22 
 
Figure 5 - Nucleotide usage frequency at positions with transmissible variants in human viral HA genes 
Full-length Human H1N1/2009 (2009-2013, N=9870; upper panel) and H3N2 (2008-2013, 
N=4587; lower panel) HA sequences were downloaded from GenBank. Using the HK data set to 
select sites where minor variants were shared within or between households, we summarized the 
frequency of these polymorphic sites across different years for each subtype. Data were further 
subdivided into lineages (H1N1: clade 6 and clade 7; H3N2: A/Perth/16/2009 and 
A/Victoria/208/2009). Boxplots show the median of the frequency; the bottom and top of each 
box represent the first and third quartiles. The length of the whiskers is defined as a function of 
the inner quartile range and they extend to the most extreme data point within the 75%-25% data 
range. Outliers are marked by black dots. 
 
This phenomenon is more pronounced for variants from the A/Victoria/208/2009-like lineage, in 
sharp contrast to the decreasing trend observed for the A/Perth/16/2009-like lineage. However, 
we did not see such a trend in pandemic H1N1 after the 2009 season. Additionally, frequency 
variations in H1N1/2009 are far less common than in H3N2. One should note that the 
A/Victoria/208/2009-like virus replaced the A/Perth/16/2009-like virus as the dominant lineage 
in recent years, leading to a change of vaccine strain from A/Perth/16/2009-like virus to 
A/Victoria/208/2009-like virus in 2012. In contrast, pandemic H1N1 virus is antigenically stable 
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and there was no change of vaccine strain after its introduction in humans in 2009. Overall, our 
data indicate that some synonymous/non-synonymous mutations could be transmitted between 
individuals at low frequency levels. Genetic distance between samples 
Since each virus sample collected in our study will contain de novo mutations and/or 
potentially represent a mixed infection, we determined the similarity of the viral populations 
across the data set. To this end we calculated the genetic distance between samples by 
performing an all-versus-all pairwise comparison for each variant nucleotide position using an 
L1-norm. We grouped pairwise comparisons by longitudinal pairs (same individual, sampled at 
two different visits), transmission pairs (within households), and across household pairs (Figure 
6).  
 
 
Figure 6 - Box-plots of L1-norm pairwise genetic distance within and across households 
We use the L1-norm values obtained from the variant nucleotide analysis across all genes to 
compare overall genetic distance of longitudinal pairs (there are 16 individuals in 12 households 
who have been sampled at two different time points, 2-3 days apart) and transmission pairs (there 
are 13 households where at least 2 members have been sampled, with a total of 22 predicted 
 24 
donor and recipient pairs within households, and 22 more when including more than one time 
point per individual), compared to all other comparisons across households (every other possible 
sample pair combination). The boxplots show the median of the distances; the bottom and top of 
each box represent the first and third quartiles. The lengths of the whiskers extend to 1.5 times 
the interquartile range. Outliers are marked by black dots. The dashed black circle in the 
H1N1/2009 plot marks the outliers. One of the H1N1/2009 pairs—household 751, index case 
(0), visit 1 and visit 2: 751_V1(0) and 751_V2(0)—had a pairwise genetic distance that was 
above the expected threshold (H1N1/2009, Longitudinal). When each of these was then used in 
within household pairwise comparisons (H1N1/2009, Transmission), the visit 2 sample appeared 
clearly as an outlier. The pairwise genetic distance between the index case in household 667 
(667_V1(0)) and its other household member (667_V2(3)) also appeared as an outlier pair. 
 
We determined that the median L1 genetic distances between household pairs or longitudinal 
pairs are significantly closer than any random pairing, while within household median genetic 
distance is not significantly different than that observed for longitudinal pairs, indicating minor 
variants and their proportions can be used to infer inter-host transmission, even if a number of 
these correspond to co-infecting variants that are shared with individuals across households. 
Interestingly, for H1N1/2009 we see a few “within household” pairs that are outliers (Figure 6, 
dashed circle), further evidence of mixed infection. For example, the visit 2 sample for the index 
case of household 751 (751_V2(0)) has multiple polymorphic major sites as compared to the 
other samples from the same household, including its visit 1 sample (751_V1(0)). Similarly, for 
the index case of household 667 (667_V1(0)), SNV frequencies are different when compared to 
the contact case (667_V2(3)). These also demonstrate that some minor variants can occasionally 
become dominant after a single transmission. 
2.3.3 Transmission network 
After excluding outliers and considering only a single sample (visit 1) per individual, there were 
21 viable “within household” transmission pairs. To select other potential epidemic links within 
the community, outside of the household transmissions, we used the transmission and 
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longitudinal pairs to identify outliers and determine a threshold of maximum genetic distance 
(after excluding outliers) (Figure 6). Each pair was epidemiologically linked to a short 
transmission chain (see below). Using the consensus sequences, we inferred transmission 
networks across the population using a parsimony and graph-based algorithm (36, 37).  
 
Figure 7 - Reconstruction of potential transmission pathways of H1N1/2009 
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Figure 8 - Reconstruction of potential transmission pathways of H3N2 outbreaks 
Transmission networks are inferred from the consensus whole genome sequences and date of 
onset. Each sample is a node on the graph and the directed edges indicate putative ancestries and 
transmissions. Time is represented on the x axis and shows the number of days since the first 
date of onset. A unique color is assigned to households with more than one member sampled. 
The size of the node is determined by the number of out degrees. A dashed line indicates a 
putative transmission link greater than 10 days. The weight of an edge indicates the number of 
nucleotide differences between two samples (a darker edge = smaller number of differences); 
Nucleotide differences were separated into quartiles. H1N1/2009: 0-2 nt; 3-6 nt; 7-15 nt; 16-28 
nt. H3N2: 0-5 nt; 6-9 nt; 10-19 nt; 20-45 nt. Circles with thick black edges are nodes within a 
chain of transmission with more than 2 individuals. Locality and age of the patient is indicated 
for a number of the nodes. HK: Hong Kong; NT: New Territories; KLN: Kowloon. 
 
We then use minor variant data to highlight potential localized outbreaks (Figure 7 and Figure 
8) with cross-region links (i.e. Hong Kong Island, Kowloon and New Territories). This also 
agrees with the fact that there is a high volume of population flow within Hong Kong each day, 
allowing ample opportunity for influenza transmission across regions. 
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2.3.4 Shared viral populations 
To further explore shared virus populations within households, we compared minor variants at 
each position in donor (index cases) and recipient transmission pair samples.  
 
Figure 9 - Box-plots comparing shared variant frequencies within and across households 
We compared shared variant frequencies between samples from index cases and their household 
members (colored dots) or with any other sample (black dots). White boxes indicate interquartile 
ranges and white dots indicate outliers. Household members tend to share most of the variants 
found in the index case. 
 
Most variants found in the donor were shared with the potential recipient (Figure 9, colored 
dots). The frequency of shared variants is much lower in pairs of unrelated samples (Figure 9, 
black dots), although we find more shared variants in H3N2 than in H1N1/2009 pairs. We 
observe that the relative frequency of variants in the recipient is more often similar to that found 
in the donor, which is not the case for the same variants found in any other individual (Wilcoxon 
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signed-rank test, p < 0.05). This suggests shared variants found in the recipient are not the result 
of de novo mutation but are more likely present in viruses that transmit and replicate.  
2.3.5 Effective population sizes 
From the household transmission pairs we estimated the number of variants that can achieve 
sustainable transmission in new hosts. Polymorphic sites with variants only detected in the donor 
and those detected in both donor and recipient samples were selected to determine the probability 
of transmission as a function of variant frequency. Accordingly, for H1N1/2009, a donor variant 
found at a frequency of 10% has a 64% chance of being transmitted to the recipient; for H3N2, a 
donor variant at 10% has an 86% chance of transmission (Figure 10). Because of limited sample 
size it was not possible to determine with confidence the probability of transmission for variants 
present at frequencies below 10%. 
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Figure 10 - Probability of variant transmission as a function of relative frequency of the minor 
variants 
Variants that were only detected in the donor and those that were shared between donor and 
recipient samples were used in determining the probability of transmission. Household pairs (red 
dots) are comparisons between members of the same household. Each point is the proportion of 
shared variants over the total number of variants found in a window size of 10%. Random pairs 
(green shaded area) are 30 random donor/recipient pairs resampled 100 times to get a standard 
deviation estimate. 
 
To infer the size of the virus population before and after transmission that is able to 
generate productive progeny, we estimated the effective population size, Ne, using a modified  
version of the Wright-Fisher (WF) idealized population model for our dataset. Specifically, for 
our donor/recipient pairs we take the frequency of the shared minor variants, p; the frequency of 
the major nucleotide at that position, q; and then calculate the variance of the difference in 
donor/recipient frequencies, to obtain a variance effective size. For this we obtain a mean of 192 
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viral particles (median 123) for H1N1/2009 and a mean of 248 (median 138) for H3N2. To 
confirm the scale of our estimates, we utilized a different method based on the Kullback-Leibler 
divergence (KLD) to estimate an effective size. This gave a mean of 90 (median 80) for 
H1N1/2009 and a mean of 114 (median 121) for H3N2. To estimate how many haplotypes 
would be present within these replicating populations, we phased SNVs for the HA segment and 
reconstructed haplotypes by single molecule sequencing. From this, we observed an average of 
three haplotypes transmitted across donor/recipient pairs for both H1N1/2009 and H3N2, taking 
into account phased SNVs for HA. Previous empirical data for H3N2 is of the same order of 
magnitude as these inferred values (38) and with previous observations that seasonal H3N2 has 
more co-circulating lineages than pandemic H1N1 (25, 39). Crucially, these effective population 
and haplotype estimates suggest that multiple variants can be routinely transmitted between 
individuals, such that any transmission bottlenecks are relatively loose, and that a relatively 
small number of viral particles can initiate a productive infection with a number of variant strains 
that are co-transmitted.  
2.4 DISCUSSION 
We analyzed minor variant dynamics in the transmission of the influenza A virus within and 
across households during an epidemic. In particular, we used shared minor variant information 
between donors and recipients in transmission pairs to estimate the number of viral particles that 
are able to infect and replicate in the recipient, and which revealed the transmission of multiple 
variants. Our approach could help define how prior immunity or other host factors, as well as 
virus subtype and strain, may affect transmission dose, which our effective size estimates likely 
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capture lower bounds on. We also demonstrate that there are likely more cases of mixed strains 
within infected patients than can be captured with standard consensus-based diagnostic assays. 
Such co-infections will obviously facilitate the occurrence of reassortment, and may help explain 
the frequent detection of reassortants between seasonal H3 viruses (40). For some of the co-
infected patients we observe potential competition between two strains with different lineages 
dominating the population found in each individual. Although similar observations have been 
made in infected animals (37, 41), ours is the first demonstration for influenza A virus in 
humans. Overall, characterizing the genetic information of transmitted virions allows a better 
understanding of influenza virus transmission, and provides more accurate information for 
modeling epidemics and disease control strategies.  
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3.0  CONCLUSIONS AND FUTURE PERSPECTIVES 
This work provides a new analysis framework to better understand the structure of influenza A 
virus populations within infected hosts and influenza transmission dynamics. Due to the now 
ubiquitous nature of NGS with deep sequencing and single molecule sequencing capabilities, we 
can collect detailed information on virus genetic information and evolution in an infection. This 
can be used in conjunction with epidemiological data to estimate the effective population size at 
transmission and how prior immunity or other host factors or virus subtype and strain may affect 
that number. These types of analyses also enable us to look at mixed infections, such as co-
infections with two strains of the same influenza A subtype, or two different subtypes—which 
we observed in one of our Hong Kong patients—and, potentially, different respiratory viruses. 
These would likely have been ignored in standard consensus-based diagnostic assays.  
Future work will include the same type of analyses to characterize transmission networks 
of school-age children in Pittsburgh schools. Using the variant data information, we can follow 
minor strains over the course of an epidemic and reconstruct chains of transmission. The next 
steps will be to link the symptom onset data with our variant analysis to create a transmission 
model. Preliminary results indicate that there may be multiple variants transmitted. This again 
suggests that the genetic diversity within an individual plays a much larger role than what is 
depicted by the consensus sequence alone. 
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These studies highlight the power of NGS for the fine characterization of viral populations 
within infected hosts. These data can be overlaid onto epidemiological maps to get better 
resolution in transmission networks during epidemics.  
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